Market Scan

Tassilo Pellegrini's picture

Leveraging Private Cloud Technologies to Improve Prior Investments in Semantic Technologies and Data Warehouses

05. December 2012

BIOIT WORLD: Pharmaceutical R&D divisions normally possess a significant amount of warehoused legacy data that bears directly on other areas of the enterprise, such as new product development, manufacturing pipelines, clinical studies, regulatory affairs, etc., where a better understanding and reuse of data can be beneficial from a cost and productivity standpoint.  In large enterprises, it can be difficult for scientists, engineers, management and other stakeholders to quickly and effectively access pertinent data that allow for improved business decisions.  Getting that data out of legacy  systems can be difficult, which is one of the reasons that semantic technologies have been sought after for some years in the pharmaceutical and bio-tech areas. 

The Value of Semantics 

[read more]